Related Experiment Video
Updated: Jul 10, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation:
Mark T Mills1, Peter Calvert1, Periaswamy Velavan2
1Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK; Department of Cardiology, Liverpool Heart & Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool L14 3PE, UK.
Insights
Concurrent left atrial appendage occlusion (LAAO) and atrial fibrillation (AF) ablation offers a combined approach to managing AF, potentially improving outcomes by addressing both stroke risk and symptoms simultaneously.
Area of Science:
- Cardiology
- Interventional Electrophysiology
- Medical Device Technology
Background:
- Atrial fibrillation (AF) management requires stroke prevention and symptom control.
- Percutaneous left atrial appendage occlusion (LAAO) reduces stroke risk in high-risk AF patients intolerant to anticoagulants.
- Catheter ablation alleviates AF burden and improves quality of life in symptomatic patients.
Purpose of the Study:
- To review the evidence for and against performing LAAO and AF catheter ablation concurrently.
- To discuss procedural considerations, safety, and efficacy of combined procedures.
- To explore future directions in simultaneous AF management interventions.
Main Methods:
- Review of existing literature on concurrent LAAO and AF catheter ablation.
- Analysis of procedural sequencing, antithrombotic therapy, and outcomes.
- Synthesis of data regarding safety and efficacy of combined interventions.
Main Results:
- Concurrent procedures are gaining traction due to advancements in techniques.
- Traditionally, LAAO and AF ablation were performed separately due to procedural time and risks.
- Evidence for and against the combined approach is summarized, including safety and efficacy data.
Conclusions:
- Concurrent LAAO and AF catheter ablation is a developing strategy for comprehensive AF management.
- Careful consideration of procedural details, sequencing, and post-procedural care is crucial.
- Further research is needed to fully establish the role and optimize outcomes of combined interventions.
Abstract:
Stroke prevention and symptom control are two integral pillars in atrial fibrillation (AF) management. Percutaneous left atrial appendage occlusion (LAAO) is effective at reducing stroke risk in high-risk patients with AF who cannot tolerate oral anticoagulant therapy, whilst catheter ablation is effective at reducing AF burden and improving quality-of-life in patients who remain symptomatic despite medical therapy. If both procedures are indicated in an individual patient, they have traditionally been performed on separate occasions, due to long cumulative procedural times, itself associated with thromboembolic risk. Recently, with the advancement of procedural techniques, the concept of concurrent LAAO and AF catheter ablation has gained traction. This review summarises the evidence for and against concurrent LAAO and AF catheter ablation, discussing procedural considerations, including procedural sequencing and post-procedural antithrombotic therapy, safety and efficacy outcomes, and future directions in the field.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
01:21Cardiac Catheterization II: Right Heart Catheterization